| Golder N Wilson, MD | |
|
3601 4th St, Ms 9406, Lubbock, TX 79430-0002 | |
| (806) 743-7337 | |
| (806) 743-7329 |
| Full Name | Golder N Wilson |
|---|---|
| Gender | Male |
| Speciality | Medical Genetics And Genomics |
| Experience | 52 Years |
| Location | 3601 4th St, Lubbock, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063402840 | NPI | - | NPPES |
| 119194212 | Medicaid | TX | |
| 127048101 | Other | TX | FIRSTCARE COMMERCIAL |
| 119194205 | Medicaid | TX | |
| 8H8760 | Other | TX | BC/BS |
| 119194204 | Medicaid | TX | |
| 119194211 | Medicaid | TX | |
| 127048102 | Medicaid | TX | |
| 87286Z | Other | TX | HMO BLUE |
| Y0069496 | Other | TX | DPS |
| A562 | Other | NM | TRIWEST |
| 82994 | Other | NM | PRESBYTERIAN COMMERCIAL |
| 82994 | Medicaid | NM | |
| 100056830 A | Medicaid | OK | |
| 119194216 | Medicaid | TX | |
| 31405762 | Medicaid | NM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | H5095 (Texas) | Secondary |
| 207SG0201X | Medical Genetics - Clinical Genetics (m.d.) | H5095 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Texas Tech University Health Sciences Center Lubbock | 4385549674 | 310 |
News Archive
Stemedica Cell Technologies , Inc., ("Stemedica"), a world leader in stem cell research and manufacturing (a licensed manufacturer of clinical grade biological products as licensed by the State of California Food and Drug Branch) continues to advance the stem cell industry with the presentation of two of its latest scientific discoveries at the 2009 World Stem Cell Summit.
New research from the University of Georgia finds that older Mexican Americans who live in low English-speaking neighborhoods are at greater risk for poor health and even an early death.
Children exposed to polychlorinated biphenyls early in life later had a diminished immune response to diphtheria and tetanus vaccinations, according to a study published online June 20 ahead of print in the peer-reviewed journal Environmental Health Perspectives. This result suggests that PCB exposure during the first years of life, a critical period in immune system development, could undermine the effectiveness of childhood vaccinations and possibly impair immune system responses to infection.
Advaxis, Inc., the live, attenuated Listeria monocytogenes (Lm) immunotherapy company, completes recruitment of the first group of patients in its US cervical dysplasia (CIN) phase II study of ADXS11-001 as required for the planned DMSB (safety board) meeting scheduled to be held January 11, 2011.
An exciting, 'tour-de-force' paper by researchers from the Massachusetts Institute of Technology describes de novo discovery of high-affinity peptide binders for SARS-CoV-2 spike glycoprotein, which opens the door for the development of rapid viral identification or conjugates for virus-directed delivery of therapeutics.
› Verified 1 days ago
| Entity Name | Texas Tech University Health Sciences Center Lubbock |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063461358 PECOS PAC ID: 4385549674 Enrollment ID: O20110318000468 |
News Archive
Stemedica Cell Technologies , Inc., ("Stemedica"), a world leader in stem cell research and manufacturing (a licensed manufacturer of clinical grade biological products as licensed by the State of California Food and Drug Branch) continues to advance the stem cell industry with the presentation of two of its latest scientific discoveries at the 2009 World Stem Cell Summit.
New research from the University of Georgia finds that older Mexican Americans who live in low English-speaking neighborhoods are at greater risk for poor health and even an early death.
Children exposed to polychlorinated biphenyls early in life later had a diminished immune response to diphtheria and tetanus vaccinations, according to a study published online June 20 ahead of print in the peer-reviewed journal Environmental Health Perspectives. This result suggests that PCB exposure during the first years of life, a critical period in immune system development, could undermine the effectiveness of childhood vaccinations and possibly impair immune system responses to infection.
Advaxis, Inc., the live, attenuated Listeria monocytogenes (Lm) immunotherapy company, completes recruitment of the first group of patients in its US cervical dysplasia (CIN) phase II study of ADXS11-001 as required for the planned DMSB (safety board) meeting scheduled to be held January 11, 2011.
An exciting, 'tour-de-force' paper by researchers from the Massachusetts Institute of Technology describes de novo discovery of high-affinity peptide binders for SARS-CoV-2 spike glycoprotein, which opens the door for the development of rapid viral identification or conjugates for virus-directed delivery of therapeutics.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Golder N Wilson, MD Po Box 5865, Lubbock, TX 79408-5865 Ph: (806) 743-2898 | Golder N Wilson, MD 3601 4th St, Ms 9406, Lubbock, TX 79430-0002 Ph: (806) 743-7337 |
News Archive
Stemedica Cell Technologies , Inc., ("Stemedica"), a world leader in stem cell research and manufacturing (a licensed manufacturer of clinical grade biological products as licensed by the State of California Food and Drug Branch) continues to advance the stem cell industry with the presentation of two of its latest scientific discoveries at the 2009 World Stem Cell Summit.
New research from the University of Georgia finds that older Mexican Americans who live in low English-speaking neighborhoods are at greater risk for poor health and even an early death.
Children exposed to polychlorinated biphenyls early in life later had a diminished immune response to diphtheria and tetanus vaccinations, according to a study published online June 20 ahead of print in the peer-reviewed journal Environmental Health Perspectives. This result suggests that PCB exposure during the first years of life, a critical period in immune system development, could undermine the effectiveness of childhood vaccinations and possibly impair immune system responses to infection.
Advaxis, Inc., the live, attenuated Listeria monocytogenes (Lm) immunotherapy company, completes recruitment of the first group of patients in its US cervical dysplasia (CIN) phase II study of ADXS11-001 as required for the planned DMSB (safety board) meeting scheduled to be held January 11, 2011.
An exciting, 'tour-de-force' paper by researchers from the Massachusetts Institute of Technology describes de novo discovery of high-affinity peptide binders for SARS-CoV-2 spike glycoprotein, which opens the door for the development of rapid viral identification or conjugates for virus-directed delivery of therapeutics.
› Verified 1 days ago